Neurocrine Biosciences Inc
F:NB3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neurocrine Biosciences Inc
F:NB3
|
US |
|
C
|
CECO Environmental Corp
F:WCE
|
US |
|
M
|
Marathon Digital Holdings Inc
XMUN:M44
|
US |
|
Y
|
Yamaha Motor Co Ltd
XBER:YMA
|
JP |
|
P
|
PostNL NV
XMUN:TNTC
|
NL |
|
M
|
Mitsui Chemicals Inc
XMUN:MSI
|
JP |
|
C
|
Charles Schwab Corp
XMUN:SWG
|
US |
|
S
|
Starpharma Holdings Ltd
XMUN:PQ6
|
AU |
|
F
|
First Solar Inc
DUS:F3A
|
US |
|
Ki Group Holding SpA
MIL:KI
|
IT |
|
Bushveld Minerals Ltd
F:23U
|
ZA |
|
C
|
China Longyuan Power Group Corp Ltd
F:6WX
|
CN |
|
G
|
GTI Resources Ltd
XBER:3G4
|
AU |
|
Tesla Inc
LSE:0R0X
|
US |
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
NL |
|
E
|
Equinor ASA
SWB:DNQA
|
NO |
|
C
|
C&C Group PLC
OTC:CGPZF
|
IE |
|
H
|
Hannover Rueck SE
XMUN:HNR1
|
DE |
|
Atari SA
LSE:0KUV
|
FR |
|
Emmi AG
F:FV6
|
CH |
|
I
|
Intuitive Surgical Inc
XHAM:IUI1
|
US |
Wall St Price Targets
NB3 Price Targets Summary
Neurocrine Biosciences Inc
According to Wall Street analysts, the average 1-year price target for NB3 is 151.3 EUR with a low forecast of 114.73 EUR and a high forecast of 203.76 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NB3's stock price target?
Price Target
151.3
EUR
According to Wall Street analysts, the average 1-year price target for NB3 is 151.3 EUR with a low forecast of 114.73 EUR and a high forecast of 203.76 EUR.
What is the Revenue forecast for Neurocrine Biosciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Neurocrine Biosciences Inc?
Projected CAGR
30%
Over the last 13 years, the compound annual growth rate for Operating Income has been 53%. The projected CAGR for the next 8 years is 30%.
What is the Net Income forecast for Neurocrine Biosciences Inc?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 8 years is 18%.
